Santhera Pharmaceuticals Holding AG (SWX:SANN)

SWX:SANN Balance Sheet

Financials in millions CHF. Fiscal year is January - December.

Assets

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	22.44	40.93	30.37	1.35	21.21
Cash & Short-Term Investments	22.44	40.93	30.37	1.35	21.21
Cash Growth	-45.17%	34.76%	2144.64%	-93.62%	70.88%
Accounts Receivable	8.7	9.06	0.44	0.44	0.96
Other Receivables	17.33	4.83	1.72	0.65	0.97
Receivables	26.04	13.89	2.16	1.09	1.94
Inventory	24.87	17.53	1.81	0.11	0.43
Prepaid Expenses	0.58	0.37	0.32	0.51	1.07
Other Current Assets	6.32	3.1	-	-	-
Total Current Assets	80.24	75.81	34.66	3.07	24.64
Property, Plant & Equipment	2.01	2.57	0.58	1.01	1.32
Long-Term Investments	0.32	0.25	0.42	0.44	0.47
Other Intangible Assets	63.94	68.95	73.97	59.21	64.6
Long-Term Deferred Tax Assets	-	-	-	0	0.09
Other Long-Term Assets	1.58	4.91	-	-	-
Total Assets	148.09	152.49	109.63	63.73	91.12

Liabilities

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	13.58	5.75	3.56	3.9	2.41
Accrued Expenses	19.4	19.35	9.57	10.85	9.71
Short-Term Debt	-	-	-	22.13	1.49
Current Portion of Long-Term Debt	14.26	6.4	20.94	-	13.88
Current Portion of Leases	0.59	0.55	0.57	0.62	0.61
Current Income Taxes Payable	0.89	0.14	0.18	0.55	0.27
Current Unearned Revenue	0.14	0.06	-	-	-
Other Current Liabilities	13.31	13.9	10.97	11.36	4.42
Total Current Liabilities	62.17	46.14	45.79	49.41	32.78
Long-Term Debt	32.73	31.73	-	21.08	25.8
Long-Term Leases	1.37	1.94	0.04	0.61	1.2
Long-Term Unearned Revenue	3.16	1.93	-	-	-
Pension & Post-Retirement Benefits	6.52	7.67	3.86	1.84	4.79
Other Long-Term Liabilities	53.96	35.38	-	34.47	25.21
Total Liabilities	159.9	124.79	49.69	107.41	89.79

Shareholders' Equity

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	1.4	1.34	1.26	0.75	54.61
Retained Earnings	-663.93	-614.69	-572.72	-627.5	-556.43
Treasury Stock	-0.06	-0.07	-0.13	-0.09	-5.02
Comprehensive Income & Other	650.77	641.11	631.53	583.16	508.17
Shareholders' Equity	-11.82	27.7	59.94	-43.69	1.33
Total Liabilities & Equity	148.09	152.49	109.63	63.73	91.12

Additional Metrics

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	48.95	40.62	21.55	44.44	42.98
Net Cash (Debt)	-26.51	0.31	8.82	-43.08	-21.77
Net Cash Growth	-	-96.54%	-	-	-
Net Cash Per Share	-2.04	0.03	0.81	-7.07	-6.37
Filing Date Shares Outstanding	13.39	12.79	11.32	6.59	4.96
Total Common Shares Outstanding	13.39	12.79	11.32	6.59	4.96
Working Capital	18.07	29.67	-11.14	-46.35	-8.14
Book Value Per Share	-0.88	2.17	5.30	-6.63	0.27
Tangible Book Value	-75.75	-41.25	-14.02	-102.89	-63.27
Tangible Book Value Per Share	-5.66	-3.22	-1.24	-15.62	-12.76
Machinery	1.51	1.46	1.35	1.46	1.82
Leasehold Improvements	1.48	1.48	1.48	1.5	1.54

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 22, 2026

Data Sources Report a data error